Roxanne Austin

(Ms. Roxanne Austin)

Currently holds positions in Abbott Laboratories, Teledyne Technologies Inc, Abbvie Inc and Target Corp

Positions
Position Company Period
Independent Director Abbott Laboratories Dec. 8, 2000 -
Independent Director Teledyne Technologies Inc Oct. 10, 2006 -
Independent Director Abbvie Inc Jan. 2, 2013 -
Independent Director Target Corp Aug. 12, 2014 -
Independent Director Telefonaktiebolaget LM Ericsson March 3, 2008 - April 13, 2016
Independent Interim Non-Executive Chairman of the Board Target Corp May 5, 2014 - Aug. 12, 2014
Independent Director Target Corp Jan. 1, 2002 - May 5, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-02-09 2024-02-09
PS Planned sale
6,303 -6.7%
21.54
135,767 USD 		6,303 -6.7% 21.54 135,767 USD
2024-01-10 2024-01-09
PS Planned sale
6,303 -6.2%
22.58
142,322 USD 		6,303 -6.2% 22.58 142,322 USD
2023-10-13 2023-10-11
S Sale
5,000 -22.1%
185.25
926,250 USD 		5,000 -22.1% 185.25 926,250 USD
2023-10-10 2023-10-10
S Sale
5,000 -18.1%
185.01
925,050 USD 		5,000 -18.1% 185.01 925,050 USD
2023-10-11 2023-10-09
PS Planned sale
6,303 -5.3%
19.20
121,018 USD 		6,303 -5.3% 19.20 121,018 USD
2023-10-10 2023-10-06
S Sale
5,000 -15.3%
172.25
861,250 USD 		5,000 -15.3% 172.25 861,250 USD
2023-10-10 2023-10-06
S Sale
5,000 -13.3%
172.01
860,050 USD 		5,000 -13.3% 172.01 860,050 USD
2023-09-12 2023-09-11
PS Planned sale
6,303 -5.0%
22.07
139,107 USD 		6,303 -5.0% 22.07 139,107 USD
2023-08-10 2023-08-09
PS Planned sale
6,298 -4.8%
21.47
135,218 USD 		6,298 -4.8% 21.47 135,218 USD
2023-07-12 2023-07-10
PS Planned sale
6,303 -4.6%
16.19
102,046 USD 		6,303 -4.6% 16.19 102,046 USD
2023-07-03 2023-07-03
PS Planned sale
7,962 -5.5%
17.35
138,141 USD 		7,962 -5.5% 17.35 138,141 USD
2023-06-09 2023-06-09
PS Planned sale
25,212 -15.9%
15.76
397,341 USD 		25,212 -15.9% 15.76 397,341 USD
2023-02-21 2023-02-17
US Abbvie Inc (ABBV)
S Sale
10,000 -19.7%
150.50
1,505,000 USD 		10,000 -19.7% 150.50 1,505,000 USD
2023-02-14 2023-01-05
B Purchase
15,500 +15.4%
99.00
1,534,500 USD 		15,500 +15.4% 99.00 1,534,500 USD
2023-01-06 2023-01-05
B Purchase
15,000 +17.6%
97.59
1,463,900 USD 		15,000 +17.6% 97.59 1,463,900 USD
2023-01-06 2023-01-05
B Purchase
20,000 +30.6%
95.14
1,902,800 USD 		20,000 +30.6% 95.14 1,902,800 USD
2022-12-29 2022-12-28
B Purchase
10,000 +18.0%
99.31
993,100 USD 		10,000 +18.0% 99.31 993,100 USD
2022-12-29 2022-12-27
B Purchase
15,000 +37.1%
100.03
1,500,401 USD 		15,000 +37.1% 100.03 1,500,401 USD
2021-11-04 2021-11-03
US Abbvie Inc (ABBV)
S Sale
20,000 -28.9%
117.23
2,344,600 USD 		20,000 -28.9% 117.23 2,344,600 USD
2021-11-04 2021-11-02
US Abbvie Inc (ABBV)
S Sale
6,844 -9.0%
115.23
788,634 USD 		6,844 -9.0% 115.23 788,634 USD
2021-11-04 2021-11-02
US Abbvie Inc (ABBV)
S Sale
25,000 -24.7%
116.11
2,902,750 USD 		25,000 -24.7% 116.11 2,902,750 USD
2021-11-04 2021-11-02
US Abbvie Inc (ABBV)
S Sale
20,000 -16.5%
117.10
2,342,000 USD 		20,000 -16.5% 117.10 2,342,000 USD
2021-10-18 2021-10-14
S Sale
10,000 -38.5%
274.75
2,747,500 USD 		10,000 -38.5% 274.75 2,747,500 USD
2020-12-08 2020-12-07
S Sale
35,000 -57.1%
170.00
5,950,000 USD 		35,000 -57.1% 170.00 5,950,000 USD
2020-10-14 2020-10-12
S Sale
8,000 -15.4%
149.23
1,193,840 USD 		8,000 -15.4% 149.23 1,193,840 USD
2020-10-07 2020-10-05
S Sale
2,000 -3.7%
145.73
291,460 USD 		2,000 -3.7% 145.73 291,460 USD
2019-08-02 2019-08-01
US Abbvie Inc (ABBV)
B Purchase
25,000 +27.1%
65.66
1,641,400 USD 		25,000 +27.1% 65.66 1,641,400 USD
2019-08-02 2019-07-31
US Abbvie Inc (ABBV)
B Purchase
30,000 +48.3%
66.02
1,980,690 USD 		30,000 +48.3% 66.02 1,980,690 USD
2019-07-31 2019-07-30
US Abbvie Inc (ABBV)
B Purchase
10,000 +19.2%
66.35
663,500 USD 		10,000 +19.2% 66.35 663,500 USD
2019-06-28 2019-06-26
US Abbvie Inc (ABBV)
B Purchase
11,500 +28.3%
67.50
776,250 USD 		11,500 +28.3% 67.50 776,250 USD